Multivariable analysis by donor group in the CNI cohort
| End point . | MSD vs MUD HR (95% CI) . | P value . |
|---|---|---|
| OS | 1.03 (0.97-1.09) | .3703 |
| DFS | 1.09 (1.04-1.15) | .0012 |
| NRM | 0.94 (0.86-1.03) | .1619 |
| Relapse | 1.23 (1.15-1.33) | <.0001 |
| Chronic GVHD∗ | 0.86 (0.81-0.91) | <.0001 |
| End point . | MSD vs MUD HR (95% CI) . | P value . |
|---|---|---|
| OS | 1.03 (0.97-1.09) | .3703 |
| DFS | 1.09 (1.04-1.15) | .0012 |
| NRM | 0.94 (0.86-1.03) | .1619 |
| Relapse | 1.23 (1.15-1.33) | <.0001 |
| Chronic GVHD∗ | 0.86 (0.81-0.91) | <.0001 |
| End point . | MSD vs MUD OR (95% CI) . | P value . |
|---|---|---|
| Grade 2-4 acute GVHD | 0.77 (0.71-0.84) | <.0001 |
| Grade 3-4 acute GVHD | 0.99 (0.87-1.12) | .8607 |
| End point . | MSD vs MUD OR (95% CI) . | P value . |
|---|---|---|
| Grade 2-4 acute GVHD | 0.77 (0.71-0.84) | <.0001 |
| Grade 3-4 acute GVHD | 0.99 (0.87-1.12) | .8607 |
Moderate-severe chronic GVHD.